TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -1 | -1 | -1 | 7 | 7 | 29 | 7 | 
| S | %wins | 100 | 33 | 33 | 33 | 33 | 33 | 44 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/4/14 20:05  | 3/3/14  | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Rizzo Daniel C Jr | PA | O | SVP,Corp | S.d | -444 | 55.50 | 33 | -8 | -9 | 83 | D | 139 | 84 | 57 | 26 | 21 | 24 | 6 | 8 | -2 | -7 | -14 | -13 | -15 | -3 | 
12/13/13 19:37  | 12/11/13  | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Rizzo Daniel C Jr | PA | O | SVP,Corp | S.dm | -2,972 | 42.04 | 33 | -71 | -50 | 69 | D | 109 | 50 | 32 | 8 | 11 | -1 | -3 | -5 | 0 | 2 | 11 | 28 | 21 | 28 | 
11/27/12 17:04  | 11/27/12  | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Rizzo Daniel C Jr | PA | O | SVP,Corp | S.d | -4,395 | 27.28 | 33 | -161 | -75 | 53 | D | 34 | 51 | 27 | 15 | 13 | 4 | 5 | 4 | 0 | 1 | 1 | 5 | 14 | 63 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |